Anticancer ResJan;33(1):Intratumoural interleukin-2 therapy can induce regression of nonresectable mastocytoma in dogs. Ziekman PG1, Otter WD, Tan JF, Teske E, Kirpensteijn J, Koten JW, Jacobs JJ. Author

First Page		Document Content
Date: 2014-12-01 13:50:24 Medicine Clinical medicine Interleukins Immunology Cancer treatments Interleukin 2 Interleukin		Anticancer ResJan;33(1):Intratumoural interleukin-2 therapy can induce regression of nonresectable mastocytoma in dogs. Ziekman PG1, Otter WD, Tan JF, Teske E, Kirpensteijn J, Koten JW, Jacobs JJ. Author Add to Reading List Source URL: alsterscience.com Download Document from Source Website File Size: 59,06 KB Share Document on Facebook

	Systematic Review and Meta-Analysis of the Pathophysiology of the Animal Model for Multiple Sclerosis, Experimental Autoimmune Encephalomyelitis DocID: 1roOi - View Document
	Anticancer ResJan;33(1):Intratumoural interleukin-2 therapy can induce regression of nonresectable mastocytoma in dogs. Ziekman PG1, Otter WD, Tan JF, Teske E, Kirpensteijn J, Koten JW, Jacobs JJ. Author DocID: 1r4NE - View Document
	GENOMIC BIO MARKERS OF WELL-BEING Reciprocal regulation of the neural and innate immune systems Michael R. Irwin and Steven W. Cole DocID: 1qaDg - View Document
	Microsoft Word - Figure 3 TLR-4 activation.docx DocID: 1q7PB - View Document
	Microsoft PowerPoint - AM0010-001 TIP Mayfinal DocID: 1pufE - View Document